» Articles » PMID: 11587527

Expression of a Novel Human Ornithine Decarboxylase-like Protein in the Central Nervous System and Testes

Overview
Publisher Elsevier
Specialty Biochemistry
Date 2001 Oct 6
PMID 11587527
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Ornithine decarboxylase (ODC) is the key enzyme of polyamine synthesis. The physiological activity of ODC is associated with cell proliferation, and high ODC activities are encountered in rapidly growing cancer cells. We have cloned a cDNA for a novel human protein that is 54% identical to ODC and 45% identical to antizyme inhibitor (AZI). mRNA for ODC-paralogue (ODC-p) was found only in the central nervous system and testes, suggesting a role in terminal differentiation rather than cell proliferation. ODC-p occurs at least in eight alternatively spliced forms. In vitro translated ODC-p did not decarboxylate ornithine, whereas, in vivo, one splice variant exerted modest ODC-like activity upon expression in COS-7 cells. ODC-p has a unique mutation in cysteine 360, where this ornithine decarboxylase reaction-directing residue is substituted by a valine. This substitution might lead to an enzymatic reaction that differs from typical ODC activity. ODC-p might also function as a brain- and testis-specific AZI.

Citing Articles

Antizyme inhibitor family: biological and translational research implications.

Feng Q, Wang H, Shao Y, Xu X Cell Commun Signal. 2024; 22(1):11.

PMID: 38169396 PMC: 10762828. DOI: 10.1186/s12964-023-01445-1.


Structure and Enzymatic Activity of an Intellectual Disability-Associated Ornithine Decarboxylase Variant, G84R.

Zhou X, Schultz C, Suino Powell K, Henrickson A, Lamp J, Brunzelle J ACS Omega. 2022; 7(38):34665-34675.

PMID: 36188294 PMC: 9520691. DOI: 10.1021/acsomega.2c04702.


Ornithine decarboxylase antizyme inhibitor 2 (AZIN2) is a signature of secretory phenotype and independent predictor of adverse prognosis in colorectal cancer.

Kaprio T, Rasila T, Hagstrom J, Mustonen H, Lankila P, Haglund C PLoS One. 2019; 14(2):e0211564.

PMID: 30768610 PMC: 6377119. DOI: 10.1371/journal.pone.0211564.


The antizyme family for regulating polyamines.

Kahana C J Biol Chem. 2018; 293(48):18730-18735.

PMID: 30355739 PMC: 6290168. DOI: 10.1074/jbc.TM118.003339.


Antizyme Inhibitors in Polyamine Metabolism and Beyond: Physiopathological Implications.

Ramos-Molina B, Lambertos A, Penafiel R Med Sci (Basel). 2018; 6(4).

PMID: 30304856 PMC: 6313458. DOI: 10.3390/medsci6040089.